SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celltech Group (NYSE: CLL)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Nealon who started this subject2/4/2004 9:26:03 AM
From: nigel bates   of 123
 
SAN DIEGO, Feb. 4 /PRNewswire-FirstCall/ -- Discovery Partners International, Inc. (Nasdaq: DPII - News) announced today that it has entered into a drug discovery collaboration with Celltech (NYSE: CLL; London: CCH) to discover potential new lead compounds for one of Celltech's selected targets involved in intracellular signal transduction. DPI will make use of its comprehensive compound collection and its proprietary process and data management tools. Financial terms of the collaboration were not disclosed.

"Celltech is one of the leading biotech companies in Europe, and we are delighted that they have selected us as their discovery partner for this lead finding program," stated Taylor Crouch, President and COO for Discovery Partners. "Our integrated drug discovery capabilities allow our partners to access a wide range of novel assay and screening technologies and expertise to be applied to our large collection of proprietary compounds, increasing the likelihood of identifying promising new drug leads in a cost effective manner."

Dr. Melanie Lee, Research and Development Director for Celltech, commented: "Celltech is pleased to be working with Discovery Partners International. Their technologies provide an excellent fit with our established lead generation strategy and we expect this collaboration to complement our ongoing lead discovery programmes."

About Discovery Partners

Discovery Partners International, Inc. is a leader in drug discovery collaborations. DPI offers integrated services, products, and systems that span the drug discovery continuum, including target characterization, targeted and screening-library design and synthesis, high throughput and high content screening, lead generation and optimization, gene expression analysis, and protein crystallization. DPI has actively contributed to dozens of drug discovery collaborations, working on many of the most promising new biological target areas for the biotech and pharmaceutical industries. Discovery Partners International is headquartered in San Diego, California and has operations in the United States, Europe and India. For more information on Discovery Partners International, Inc., please visit the Company's website at discoverypartners.com .
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext